ArriVent BioPharma, Inc. ( AVBP) - Stock Earnings
AVBP Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -35.5 million USD | — USD |
| 2026Q1 | -43.3 million USD | — USD |
| 2026Q2 | -49.9 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
AVBP Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -69.3 million USD | — USD |
| 2024 | -80.5 million USD | — USD |
| 2025 | -166.3 million USD | — USD |
| 2026 Est. | — | — |
AVBP
Price: $16.54
52 week price:
Earnings Per Share: -3.55 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.3 billion